PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium; Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Belgium. Electronic address: j.favresse@labstluc.be.\', \'Department of Laboratory Medicine, Clinique St-Pierre, Ottignies, Belgium.\', \'Department of Laboratory Medicine, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Namur, Belgium.\', \'Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Belgium.\', \'Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Belgium; Qualiblood sa, Namur, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1198-743X(21)00224-X10.1016/j.cmi.2021.05.004
?:hasPublicationType
?:journal
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33975007
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all